JNJ240802C215000
- 0.13
- 0.000.00%
Johnson & Johnson Newsroom
Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ
Most U.S. Pharmas Don't Pay Any U.S. Income Tax
Why Wall Street Is Unfazed by Medicare Drug Pricing Threat
10 Health Care Stocks Whale Activity In Today's Session
FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?
Express News | Johnson & Johnson Receives Positive Chmp Opinion for Yuvanci® (Single Tablet Combination Therapy [Stct] of Macitentan and Tadalafil) for Treatment of Patients With Pulmonary Arterial Hypertension (Pah)
J&J Talc Bankruptcy Plan Appeal Denied
'Never Going to Be the Same': How Nvidia Is Trying to Revolutionize Healthcare
Johnson & Johnson | 10-Q: Quarterly report
AC Immune Stock Climbs 7% on FDA Fast Track Status for Alzheimer's Drug
Here's What To Do Next After the Big Stock Market Slide
Dow's 275-Point Rally Led By Gains In IBM, Salesforce Stocks
Looking Into Johnson & Johnson's Recent Short Interest
AbbVie Raises Outlook as New Immunology Drugs Offset Humira Impact
Newly-Listed Psoriasis Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Bio-Thera Biosimilar to J&J's Stelara Under FDA Review
Check Out What Whales Are Doing With JNJ
Johnson & Johnson (JNJ) Is Attracting Investor Attention: Here Is What You Should Know
Health Care Stocks Steady With Broader Market -- Health Care Roundup